Y. Komoike

424 total citations
12 papers, 338 citations indexed

About

Y. Komoike is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Y. Komoike has authored 12 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Y. Komoike's work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (5 papers) and HER2/EGFR in Cancer Research (3 papers). Y. Komoike is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (5 papers) and HER2/EGFR in Cancer Research (3 papers). Y. Komoike collaborates with scholars based in Japan. Y. Komoike's co-authors include Hideo Inaji, Kazuyoshi Motomura, Takeshi Imamura, Masamichi IKEDA, H. Ohtsuji, Hidekazu Koyama, Tsutomu Kasugai, Makoto Ishitobi, Annuska M. Glas and Laura J. van’t Veer and has published in prestigious journals such as Cancer Research, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Y. Komoike

11 papers receiving 316 citations

Peers

Y. Komoike
Comparison fields: 5 of 67
  • Cancer Research 199
  • Pathology and Forensic Medicine 105
  • Surgery 95
  • Oncology 85
  • Pulmonary and Respiratory Medicine 44
Replace Carmen Lilla with:
Carmen Lilla Germany
Dongxian Zhou China
Shinsuke Kira Japan
Yoshinobu Nagato Japan
Dehong Zou China
Paul-Yann Lin Taiwan
Gui-Long Guo China
Jean Weigert United States
Yao-Li Chen Taiwan
Jiin-Chyuan Luo United States
Carmen Lilla Germany View profile →
Citations per field, relative to Y. Komoike
Y. Komoike · 1×
Citations per year, relative to Y. Komoike
Y. Komoike · 1×

Countries citing papers authored by Y. Komoike

Since Specialization
Citations

This map shows the geographic impact of Y. Komoike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Komoike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Komoike more than expected).

Fields of papers citing papers by Y. Komoike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Komoike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Komoike. The network helps show where Y. Komoike may publish in the future.

Co-authorship network of co-authors of Y. Komoike

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Komoike. A scholar is included among the top collaborators of Y. Komoike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Komoike. Y. Komoike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
# Work Indexed citations
1 13
2 1
3 8
4 0
5 10
6 14
7 2
8 30
9 17
10 126
11
Nonpalpable breast cancer with nipple discharge: how should it be treated?
20
12 97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026